BV02
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-101985-5MG | 5 mg | 146,00 | Add | |
| HY-101985-1ML | 10mM/1mL | 160,00 | Add | |
| HY-101985-10MG | 10 mg | 216,00 | Add | |
| HY-101985-25MG | 25 mg | 456,00 | Add | |
| HY-101985-50MG | 50 mg | 710,00 | Add | |
| HY-101985-100MG | 100 mg | 1'217,00 | Add | |
| HY-101985-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
BV02 is a potent 4-3-3 PPI (14-3-3 protein–protein interaction) inhibitor. BV02 shows cytotoxicity for hematopoietic cells expressing the IM (imatinib mesylate)-sensitive wild type Bcr-Abl and the IM-resistant T315I mutation. BV02 has the potential for the research of chronic myeloid leukemia[1][2].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Protein Tyrosine Kinase/RTK |
| Format | Solubility: DMSO : 12.5 mg/mL (ultrasonic;warming;heat to 60°C) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.85% |
| Molecular Formula | C20H15N3O5 |
| Molecular Weight | 377.35 |
| CAS-Number | 292870-53-2 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
